Skip to main content
Erschienen in: AIDS and Behavior 3/2013

01.03.2013 | Original Paper

Acceptability of Potential Rectal Microbicide Delivery Systems for HIV Prevention: A Randomized Crossover Trial

verfasst von: Heather A. Pines, Pamina M. Gorbach, Robert E. Weiss, Kristen Hess, Ryan Murphy, Terry Saunders, Joelle Brown, Peter A. Anton, Ross D. Cranston

Erschienen in: AIDS and Behavior | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

We assessed the acceptability of three of over-the-counter products representative of potential rectal microbicide (RM) delivery systems. From 2009 to 2010, 117 HIV-uninfected males (79 %) and females (21 %) who engage in receptive anal intercourse participated in a 6-week randomized crossover acceptability trial. Participants received each of three products (enema, lubricant-filled applicator, suppository) every 2 weeks in a randomized sequence. CASI and T-ACASI scales assessed product acceptability via Likert responses. Factor analysis was used to identify underlying factors measured by each scale. Random effects models were fit to examine age and gender effects on product acceptability. Three underlying factors were identified: Satisfaction with Product Use, Sexual Pleasure, and Ease of Product Use. For acceptability, the applicator ranked highest; however, differences between product acceptability scores were greatest among females and younger participants. These findings indicate that RM delivery systems impact their acceptability and should be considered early in RM development to enhance potential use.
Literatur
1.
Zurück zum Zitat Rosenberger JG, Reece M, Schick V, et al. Sexual behaviors and situational characteristics of most recent male-partnered sexual event among gay and bisexually identified men in the United States. J Sex Med. 2011;8(11):3040–50.PubMedCrossRef Rosenberger JG, Reece M, Schick V, et al. Sexual behaviors and situational characteristics of most recent male-partnered sexual event among gay and bisexually identified men in the United States. J Sex Med. 2011;8(11):3040–50.PubMedCrossRef
2.
Zurück zum Zitat Reece M, Herbenick D, Schick V, Sanders SA, Dodge B, Fortenberry JD. Condom use rates in a national probability sample of males and females ages 14 to 94 in the United States. J Sex Med. 2010;7(Suppl 5):266–76.PubMedCrossRef Reece M, Herbenick D, Schick V, Sanders SA, Dodge B, Fortenberry JD. Condom use rates in a national probability sample of males and females ages 14 to 94 in the United States. J Sex Med. 2010;7(Suppl 5):266–76.PubMedCrossRef
3.
Zurück zum Zitat Herbenick D, Reece M, Schick V, Sanders SA, Dodge B, Fortenberry JD. Sexual behavior in the United States: results from a national probability sample of men and women ages 14–94. J Sex Med. 2010;7(Suppl 5):255–65.PubMedCrossRef Herbenick D, Reece M, Schick V, Sanders SA, Dodge B, Fortenberry JD. Sexual behavior in the United States: results from a national probability sample of men and women ages 14–94. J Sex Med. 2010;7(Suppl 5):255–65.PubMedCrossRef
4.
Zurück zum Zitat Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol. 1999;150(3):306–11.PubMedCrossRef Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol. 1999;150(3):306–11.PubMedCrossRef
5.
Zurück zum Zitat Varghese B, Maher JE, Peterman TA, Branson BM, Steketee RW. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis. 2002;29(1):38–43.PubMedCrossRef Varghese B, Maher JE, Peterman TA, Branson BM, Steketee RW. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis. 2002;29(1):38–43.PubMedCrossRef
6.
Zurück zum Zitat Mantell JE, Myer L, Carballo-Dieguez A, et al. Microbicide acceptability research: current approaches and future directions. Soc Sci Med. 2005;60(2):319–30.PubMedCrossRef Mantell JE, Myer L, Carballo-Dieguez A, et al. Microbicide acceptability research: current approaches and future directions. Soc Sci Med. 2005;60(2):319–30.PubMedCrossRef
7.
Zurück zum Zitat Gross M, Celum CL, Tabet SR, Kelly CW, Coletti AS, Chesney MA. Acceptability of a bioadhesive nonoxynol-9 gel delivered by an applicator as a rectal microbicide. Sex Transm Dis. 1999;26(10):572–8.PubMedCrossRef Gross M, Celum CL, Tabet SR, Kelly CW, Coletti AS, Chesney MA. Acceptability of a bioadhesive nonoxynol-9 gel delivered by an applicator as a rectal microbicide. Sex Transm Dis. 1999;26(10):572–8.PubMedCrossRef
8.
Zurück zum Zitat Carballo-Dieguez A, Exner T, Dolezal C, Pickard R, Lin P, Mayer KH. Rectal microbicide acceptability: results of a volume escalation trial. Sex Transm Dis. 2007;34(4):224–9.PubMedCrossRef Carballo-Dieguez A, Exner T, Dolezal C, Pickard R, Lin P, Mayer KH. Rectal microbicide acceptability: results of a volume escalation trial. Sex Transm Dis. 2007;34(4):224–9.PubMedCrossRef
9.
Zurück zum Zitat Ventuneac A, Carballo-Dieguez A, McGowan I, et al. Acceptability of UC781 gel as a rectal microbicide among HIV-uninfected women and men. AIDS Behav. 2010;14(3):618–28.PubMedCrossRef Ventuneac A, Carballo-Dieguez A, McGowan I, et al. Acceptability of UC781 gel as a rectal microbicide among HIV-uninfected women and men. AIDS Behav. 2010;14(3):618–28.PubMedCrossRef
10.
Zurück zum Zitat Anton PA, Cranston RD, Kashuba A, et al. RMP-02/MTN-006: a Phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1 % gel compared with oral tenofovir disoproxil fumarate. AIDS Res Hum Retroviruses. 2012. [Epub ahead of print]. Anton PA, Cranston RD, Kashuba A, et al. RMP-02/MTN-006: a Phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1 % gel compared with oral tenofovir disoproxil fumarate. AIDS Res Hum Retroviruses. 2012. [Epub ahead of print].
11.
Zurück zum Zitat McGowan I, Hoesley C, Andrew P, et al. MTN-007: a Phase 1 randomized, double-blind, placebo-controlled rectal safety and acceptability study of tenofovir 1 % Gel. 19th conference on retroviruses and opportunistic infections. Seattle, 2012 [abstract 34LB]. McGowan I, Hoesley C, Andrew P, et al. MTN-007: a Phase 1 randomized, double-blind, placebo-controlled rectal safety and acceptability study of tenofovir 1 % Gel. 19th conference on retroviruses and opportunistic infections. Seattle, 2012 [abstract 34LB].
12.
Zurück zum Zitat Carballo-Dieguez A, Dolezal C, Bauermeister JA, O’Brien W, Ventuneac A, Mayer K. Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men. Sex Transm Infect. 2008;84(6):483–7.PubMedCrossRef Carballo-Dieguez A, Dolezal C, Bauermeister JA, O’Brien W, Ventuneac A, Mayer K. Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men. Sex Transm Infect. 2008;84(6):483–7.PubMedCrossRef
13.
Zurück zum Zitat Coly A, Gorbach PM. Microbicide acceptability research: recent findings and evolution across phases of product development. Curr Opin HIV AIDS. 2008;3(5):581–6.PubMedCrossRef Coly A, Gorbach PM. Microbicide acceptability research: recent findings and evolution across phases of product development. Curr Opin HIV AIDS. 2008;3(5):581–6.PubMedCrossRef
14.
Zurück zum Zitat Carballo-Dieguez A, Bauermeister J, Ventuneac A, Dolezal C, Mayer K. Why rectal douches may be acceptable rectal-microbicide delivery vehicles for men who have sex with men. Sex Transm Dis. 2009;37(4):228–33. Carballo-Dieguez A, Bauermeister J, Ventuneac A, Dolezal C, Mayer K. Why rectal douches may be acceptable rectal-microbicide delivery vehicles for men who have sex with men. Sex Transm Dis. 2009;37(4):228–33.
15.
Zurück zum Zitat Gross M, Buchbinder SP, Celum C, Heagerty P, Seage GR 3rd. Rectal microbicides for U.S. gay men. Are clinical trials needed? Are they feasible? HIVNET vaccine preparedness study protocol team. Sex Transm Dis. 1998;25(6):296–302.PubMedCrossRef Gross M, Buchbinder SP, Celum C, Heagerty P, Seage GR 3rd. Rectal microbicides for U.S. gay men. Are clinical trials needed? Are they feasible? HIVNET vaccine preparedness study protocol team. Sex Transm Dis. 1998;25(6):296–302.PubMedCrossRef
16.
Zurück zum Zitat Carballo-Dieguez A, Stein Z, Saez H, Dolezal C, Nieves-Rosa L, Diaz F. Frequent use of lubricants for anal sex among men who have sex with men: the HIV prevention potential of a microbicidal gel. Am J Public Health. 2000;90(7):1117–21.PubMedCrossRef Carballo-Dieguez A, Stein Z, Saez H, Dolezal C, Nieves-Rosa L, Diaz F. Frequent use of lubricants for anal sex among men who have sex with men: the HIV prevention potential of a microbicidal gel. Am J Public Health. 2000;90(7):1117–21.PubMedCrossRef
17.
Zurück zum Zitat Carballo-Dieguez A, O’Sullivan LF, Lin P, Dolezal C, Pollack L, Catania J. Awareness and attitudes regarding microbicides and Nonoxynol-9 use in a probability sample of gay men. AIDS Behav. 2007;11(2):271–6.PubMedCrossRef Carballo-Dieguez A, O’Sullivan LF, Lin P, Dolezal C, Pollack L, Catania J. Awareness and attitudes regarding microbicides and Nonoxynol-9 use in a probability sample of gay men. AIDS Behav. 2007;11(2):271–6.PubMedCrossRef
18.
Zurück zum Zitat Javanbakht M, Murphy R, Gorbach P, LeBlanc MA, Pickett J. Preference and practices relating to lubricant use during anal intercourse: implications for rectal microbicides. Sex Health. 2010;7(2):193–8.PubMedCrossRef Javanbakht M, Murphy R, Gorbach P, LeBlanc MA, Pickett J. Preference and practices relating to lubricant use during anal intercourse: implications for rectal microbicides. Sex Health. 2010;7(2):193–8.PubMedCrossRef
19.
Zurück zum Zitat Gorbach PM, Weiss RE, Fuchs E, et al. The slippery slope: lubricant use and rectal sexually transmitted infections: a newly identified risk. Sex Transm Dis. 2012;39(1):59–64.PubMedCrossRef Gorbach PM, Weiss RE, Fuchs E, et al. The slippery slope: lubricant use and rectal sexually transmitted infections: a newly identified risk. Sex Transm Dis. 2012;39(1):59–64.PubMedCrossRef
20.
Zurück zum Zitat Stahlman S, Gorbach PM. Rectal behaviors: a global overview. Microbicides 2012. Sydney, 2012. Stahlman S, Gorbach PM. Rectal behaviors: a global overview. Microbicides 2012. Sydney, 2012.
21.
Zurück zum Zitat Weiss RE. Modeling longitudinal data. New York: Springer; 2005. Weiss RE. Modeling longitudinal data. New York: Springer; 2005.
22.
Zurück zum Zitat Martino JL, Vermund SH. Vaginal douching: evidence for risks or benefits to women’s health. Epidemiol Rev. 2002;24(2):109–24.PubMedCrossRef Martino JL, Vermund SH. Vaginal douching: evidence for risks or benefits to women’s health. Epidemiol Rev. 2002;24(2):109–24.PubMedCrossRef
23.
Zurück zum Zitat Gorbach P M, Borgerding JA, Coumi N, et al. Effects of Partnership Change on Gel Adherence in HPTN 035. Microbicides 2010. Pittsburgh, 2010. Gorbach P M, Borgerding JA, Coumi N, et al. Effects of Partnership Change on Gel Adherence in HPTN 035. Microbicides 2010. Pittsburgh, 2010.
Metadaten
Titel
Acceptability of Potential Rectal Microbicide Delivery Systems for HIV Prevention: A Randomized Crossover Trial
verfasst von
Heather A. Pines
Pamina M. Gorbach
Robert E. Weiss
Kristen Hess
Ryan Murphy
Terry Saunders
Joelle Brown
Peter A. Anton
Ross D. Cranston
Publikationsdatum
01.03.2013
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 3/2013
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-012-0358-z

Weitere Artikel der Ausgabe 3/2013

AIDS and Behavior 3/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.